Leaner and greener analysis of cannabinoids
Tóm tắt
There is an explosion in the number of labs analyzing cannabinoids in marijuana (Cannabis sativa L., Cannabaceae) but existing methods are inefficient, require expert analysts, and use large volumes of potentially environmentally damaging solvents. The objective of this work was to develop and validate an accurate method for analyzing cannabinoids in cannabis raw materials and finished products that is more efficient and uses fewer toxic solvents. An HPLC-DAD method was developed for eight cannabinoids in cannabis flowers and oils using a statistically guided optimization plan based on the principles of green chemistry. A single-laboratory validation determined the linearity, selectivity, accuracy, repeatability, intermediate precision, limit of detection, and limit of quantitation of the method. Amounts of individual cannabinoids above the limit of quantitation in the flowers ranged from 0.02 to 14.9% w/w, with repeatability ranging from 0.78 to 10.08% relative standard deviation. The intermediate precision determined using HorRat ratios ranged from 0.3 to 2.0. The LOQs for individual cannabinoids in flowers ranged from 0.02 to 0.17% w/w. This is a significant improvement over previous methods and is suitable for a wide range of applications including regulatory compliance, clinical studies, direct patient medical services, and commercial suppliers.
Tài liệu tham khảo
Lamarine RJ. Marijuana: modern medical chimaera. J Drug Educ. 2012;42:1–11.
Porter BE, Jacobson C. Report of a parent survey of cannabidiol-enriched Cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 2013;29:574–7.
Tafelski S, Häuser W, Schäfer M. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting–a systematic review of systematic reviews. Schmerz. 2015;30:14–24.
Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313:2456–73.
Bagshaw SM, Hagen NA. Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature. J Palliat Care. 2002;18:111–22.
Health Canada. Access to cannabis for medical purposes regulations. 2016: SOR/2016-230.
Mahlberg PG, Kim ES. Accumulation of cannabinoids in glandular trichomes of Cannabis (Cannabaceae). J Ind Hemp. 2004;9:15–36.
Brenneisen R. Chapter 2. Chemistry and analysis of and other Cannabis constituents. In: ElSohly MA, editor. Marijuana and the cannabinoids. New Jersey: Humana; 2006. p. 17–52.
Swift W, Wong A, Li KM, Arnold JC, McGregor IS. Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile. PLoS One. 2013;8:1–9.
Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG. Action of cannabidiol on the anxiety and other effects produced by Δ9-THC in normal subjects. Psychopharmacology. 1980;76:245–50.
Lehmann T, Brenneisen R. High performance liquid chromatographic profiling of Cannabis products. J Chromatogr. 1995;18:689–700.
Gul W, Gul SW, Radwan MM, et al. Determination of 11 cannabinoids in biomass and extracts of different varieties of Cannabis using high-performance liquid chromatography. J AOAC Int. 2015;98:1523–8.
Mudge EM, Betz JM, Brown PN. The importance of method selection in determining product integrity for nutrition research. Adv Nutr. 2016;7:390–8.
De Backer B, Debrus B, Lebrun P, et al. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in Cannabis plant material. J Chromatogr B. 2009;877:4115–24.
Mehmedic Z, Chandra S, Slade D, et al. Potency trends of Δ9-THC and other cannabinoids in confiscated Cannabis preparations from 1993 to 2008. J Forensic Sci. 2010;55:1209–17.
Smith RN, Vaughan CG. High pressure liquid chromatography of Cannabis quantitative analysis of acidic and neutral cannabinoids. J Chromatogr. 1976;129:347–54.
Alfonsi K, Colberg J, Dunn PJ, et al. Green chemistry tools to influence a medicinal chemistry and research chemistry based organization. Green Chem. 2008;10:31–6.
Watts P, Long G, Meek ME. Concise international chemical assessment document 58: chloroform. In: World Health Organization. 2004. http://www.who.int/ipcs/publications/cicad/en/cicad58.pdf Accessed 4 Jul 2016.
Center for Disease Control and Prevention. Chloroform. In: NIOSH pocket guide to chemical hazards. National Institute for Occupational Safety and Health. https://www.cdc.gov/niosh/npg/npgd0127.html. Accessed 24 Oct 2016.
AOAC International. Appendix K. Part I. AOAC guidelines for single-laboratory validation of chemical methods for dietary supplements and botanicals. In: Official methods of analysis of AOAC International. Gaithersburg MD; AOAC International; 2013. pp. 1–32.
Horwitz W. Evaluation of analytical methods used for regulation of foods and drugs. Anal Chem. 1982;4:67A–76.
Environmental Protection Agency. Guidelines establishing test procedures for the analysis of pollutants; procedures for detection and quantification. In: 40 CFR pt. 136, Appendix D, rev. 1.11. 2002. https://www.gpo.gov/fdsys/pkg/CFR-2011-title40-vol23/pdf/CFR-2011-title40-vol23-part136-appD.pdf Accessed 12 Oct 2016.
Stolker AA, van Schoonhoven J, de Vries AJ, Bobeldijk-Pastorova I, Vaes WH, van den Berg R. Determination of cannabinoids in Cannabis products using liquid chromatography-ion trap mass spectrometry. J Chromatogr A. 2004;1058:143–51.
United Nations Office on Drugs and Crime. In: Recommended methods for the identification and analysis of Cannabis and Cannabis products. New York: United Nations; 2009. pp. 1–50.
Code of Colorado Regulations. Retail marijuana code. 2013: 1 CCR 212-2.
Washington State Liquor and Cannabis Board. 2014: Initiative Measure No. 502.
Burstein SH. Determination of cannabinoids in Cannabis products using liquid chromatography-ion trap mass spectrometry. Pharmacol Ther. 1999;82:87–96.